https://ir.neuraxis.com/neuraxis-to-host-fourth-quarter-and-full-year-2025-results-and-business-update-call-on-thursday-march-19-2026/2026-03-12T13:00:00-04:00https://ir.neuraxis.com/neuraxis-achieves-major-milestone-with-ama-category-i-cpt-code-now-in-effect-establishing-a-permanent-reimbursement-pathway/2026-01-08T13:00:00-05:00https://ir.neuraxis.com/neuraxis-achieves-medical-coverage-policy-milestone-expanding-access-to-approximately-45-million-additional-covered-lives/2025-12-19T13:00:00-05:00https://ir.neuraxis.com/neuraxis-secures-veterans-affairs-federal-supply-schedule-contract-broadening-access-to-more-patients-with-functional-abdominal-pain/2025-12-01T12:00:00-05:00https://ir.neuraxis.com/neuraxis-announces-new-medical-policy-coverage-in-michigan-adding-566000-covered-lives/2025-11-12T13:00:00-05:00https://ir.neuraxis.com/neuraxis-reports-strong-third-quarter-2025-financial-results-driven-by-a-22-growth-in-revenues/2025-11-11T12:00:00-05:00https://ir.neuraxis.com/neuraxis-to-host-third-quarter-2025-results-and-business-update-call-on-tuesday-november-11-2025/2025-11-04T14:30:00-05:00https://ir.neuraxis.com/neuraxis-awarded-first-ever-fda-clearance-for-the-treatment-of-pain-in-functional-dyspepsia-fd-with-associated-nausea-symptoms-in-the-adult-patient-population/2025-10-24T13:00:00-04:00https://ir.neuraxis.com/neuraxis-to-participate-in-the-lytham-partners-fall-2025-investor-conference-on-september-30-2025/2025-09-18T13:00:00-04:00https://ir.neuraxis.com/neuraxis-reports-strong-second-quarter-2025-financial-results-driven-by-a-46-growth-in-revenues/2025-08-12T12:00:00-04:00https://ir.neuraxis.com/neuraxis-to-host-second-quarter-2025-results-and-business-update-call-on-tuesday-august-12-2025/2025-08-05T13:30:00-04:00https://ir.neuraxis.com/neuraxis-announces-new-medical-policy-coverage-with-two-health-insurers-adding-700000-covered-lives/2025-06-17T13:00:00-04:00https://ir.neuraxis.com/neuraxis-achieves-critical-milestone-secures-key-academic-society-guidelines-recommendation-for-treatment-of-functional-abdominal-pain-fap-in-ibs/2025-06-10T13:00:00-04:00https://ir.neuraxis.com/neuraxis-to-participate-in-the-lytham-partners-spring-2025-investor-conference-on-may-29-2025/2025-05-27T13:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-closing-of-5-0-million-registered-direct-offering/2025-05-22T18:03:00-04:00https://ir.neuraxis.com/neuraxis-announces-5-0-million-registered-direct-offering/2025-05-21T12:00:00-04:00https://ir.neuraxis.com/neuraxis-awarded-first-ever-fda-clearance-for-the-treatment-of-pediatric-fap-functional-dyspepsia-fd-and-associated-nausea-symptoms/2025-05-20T13:00:00-04:00https://ir.neuraxis.com/neuraxis-reports-strong-first-quarter-2025-financial-results-driven-by-a-39-growth-in-revenues/2025-05-12T13:15:00-04:00https://ir.neuraxis.com/neuraxis-to-host-first-quarter-2025-results-and-business-update-call-on-monday-may-12-2025/2025-05-05T14:00:00-04:00https://ir.neuraxis.com/neuraxis-to-present-at-the-planet-microcap-showcase-vegas-in-partnership-with-microcapclub-on-wednesday-april-23-2025-1x1-meetings-on-thursday-april-24-2025/2025-04-15T14:00:00-04:00https://ir.neuraxis.com/neuraxis-reports-strong-fourth-quarter-2024-financial-results-driven-by-a-43-increase-in-revenues/2025-03-20T13:15:00-04:00https://ir.neuraxis.com/neuraxis-to-host-fourth-quarter-and-full-year-2024-results-and-business-update-call-on-thursday-march-20-2025/2025-03-12T13:00:00-04:00https://ir.neuraxis.com/update-neuraxis-announces-new-medical-policy-coverage-with-a-prominent-insurer-for-over-five-million-lives-across-multiple-states/2025-01-21T18:45:00-05:00https://ir.neuraxis.com/neuraxis-announces-new-medical-policy-coverage-with-molina-healthcare-for-over-five-million-lives-across-multiple-states/2025-01-21T14:00:00-05:00https://ir.neuraxis.com/neuraxis-inc-issues-letter-to-shareholders/2025-01-13T14:00:00-05:00https://ir.neuraxis.com/neuraxis-inc-announces-strong-preliminary-unaudited-fourth-quarter-2024-results-revenues-increased-50-year-over-year/2025-01-08T14:00:00-05:00https://ir.neuraxis.com/neuraxis-inc-to-participate-in-the-lytham-partners-2025-investor-healthcare-summit-on-january-13-2025/2025-01-06T14:00:00-05:00https://ir.neuraxis.com/neuraxis-inc-announces-fda-510k-clearance-of-red-for-testing-and-evaluation-of-patients-with-chronic-constipation/2024-12-10T14:00:00-05:00https://ir.neuraxis.com/neuraxis-reports-strong-third-quarter-2024-financial-results-driven-by-a-40-increase-in-revenues/2024-11-12T13:10:00-05:00https://ir.neuraxis.com/neuraxis-to-host-third-quarter-2024-results-and-business-update-call-on-tuesday-november-12-2024/2024-11-05T15:00:00-05:00https://ir.neuraxis.com/neuraxis-receives-new-fda-510k-clearance-for-ib-stim-expanding-its-addressable-market/2024-11-04T15:00:00-05:00https://ir.neuraxis.com/neuraxis-announces-capital-blue-cross-medical-policy-coverage-for-penfs-effective-october-1st-2024/2024-10-29T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-new-cpt-category-i-code-for-percutaneous-electrical-nerve-field-stimulation/2024-10-22T14:00:00-04:00https://ir.neuraxis.com/neuraxis-to-participate-in-the-lytham-partners-fall-2024-investor-conference-on-october-1-2024/2024-09-19T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-geisinger-health-plan-medical-policy-coverage-for-penfs-effective-september-15-2024/2024-08-27T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-bcbs-of-vermont-medical-policy-coverage-for-penfs-effective-october-1st-2024/2024-08-13T14:00:00-04:00https://ir.neuraxis.com/neuraxis-reports-second-quarter-2024-financial-results/2024-08-09T13:00:00-04:00https://ir.neuraxis.com/neuraxis-to-host-second-quarter-2024-results-and-business-update-call-on-friday-august-9-2024/2024-08-05T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-new-submission-to-the-fda-for-the-expansion-of-its-ib-stim-label-provides-compliance-with-nyse-guidelines-on-audit-disclosure/2024-06-07T14:00:00-04:00https://ir.neuraxis.com/neuraxis-reports-first-quarter-2024-financial-results/2024-05-22T13:00:00-04:00https://ir.neuraxis.com/neuraxis-to-participate-in-the-lytham-partners-spring-2024-investor-conference-on-may-30-2024/2024-05-21T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-new-medical-policy-coverage-for-nearly-six-million-lives-in-florida/2024-05-16T14:00:00-04:00https://ir.neuraxis.com/neuraxis-to-host-first-quarter-2024-results-and-business-update-call-on-wednesday-may-22-2024/2024-05-15T21:30:00-04:00https://ir.neuraxis.com/neuraxis-announces-new-medical-policy-coverage-in-north-dakota/2024-04-23T14:00:00-04:00https://ir.neuraxis.com/neuraxis-reports-fourth-quarter-and-fiscal-year-2023-financial-results/2024-04-09T21:05:00-04:00https://ir.neuraxis.com/neuraxis-to-host-fourth-quarter-and-full-year-2023-results-and-business-update-call-on-tuesday-april-9-2024/2024-04-01T21:15:00-04:00https://ir.neuraxis.com/neuraxis-announces-ib-stim-results-from-a-large-pediatric-multi-center-registry/2024-03-27T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-highmark-bcbs-policy-coverage/2024-03-11T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-blue-cross-and-blue-shield-of-kansas-city-policy-coverage/2024-03-04T15:00:00-05:00https://ir.neuraxis.com/neuraxis-to-present-at-oppenheimer-34th-annual-healthcare-medtech-services-conference/2024-02-27T17:00:00-05:00https://ir.neuraxis.com/neuraxis-appoints-timothy-henrichs-as-chief-financial-officer/2024-01-31T15:00:00-05:00https://ir.neuraxis.com/neuraxis-inc-issues-letter-to-shareholders-from-brian-carrico-president-and-chief-executive-officer/2023-12-20T15:00:00-05:00https://ir.neuraxis.com/neuraxis-reports-third-quarter-2023-financial-results/2023-11-20T23:30:00-05:00https://ir.neuraxis.com/neuraxis-announces-carefirst-bcbs-policy-coverage/2023-11-15T15:00:00-05:00https://ir.neuraxis.com/neuraxis-secures-3-million-financing/2023-11-14T15:00:00-05:00https://ir.neuraxis.com/neuraxis-signs-exclusive-option-agreement-with-university-of-michigan-for-innovative-gastrointestinal-device/2023-11-08T15:00:00-05:00https://ir.neuraxis.com/neuraxis-announces-results-of-comparative-study-of-ib-stim-and-standard-medical-therapy-in-adolescents-with-functional-abdominal-pain-disorders/2023-09-26T14:00:00-04:00https://ir.neuraxis.com/neuraxis-reports-second-quarter-2023-financial-results/2023-09-21T13:00:00-04:00https://ir.neuraxis.com/neuraxis-to-present-at-the-gilmartin-group-emerging-growth-showcase/2023-09-13T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-publication-of-prospective-study-showing-ib-stim-improves-quality-of-life-of-adolescents-with-ibs/2023-09-12T14:00:00-04:00https://ir.neuraxis.com/neuraxis-highlights-pediatric-post-concussion-clinical-study/2023-08-29T14:00:00-04:00https://ir.neuraxis.com/neuraxis-highlights-strength-of-its-board-of-directors/2023-08-24T14:00:00-04:00https://ir.neuraxis.com/neuraxis-highlights-two-independent-studies-showing-benefits-of-ib-stim-in-adolescents-involving-the-gut-microbiome/2023-08-22T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-over-8-million-in-ib-stim-revenue/2023-08-17T14:02:00-04:00https://ir.neuraxis.com/neuraxis-announces-positive-university-of-michigan-ib-stim-cost-effectiveness-study-at-anms-2023/2023-08-15T14:00:00-04:00https://ir.neuraxis.com/neuraxis-highlights-current-commercial-insurance-coverage-with-bcbs-massachusetts-bcbs-south-carolina-bcbs-nebraska-and-quartz-wisconsin/2023-08-10T14:00:00-04:00https://ir.neuraxis.com/neuraxis-announces-pricing-of-initial-public-offering/2023-08-09T15:00:00-04:00https://ir.neuraxis.com/neuraxis-inc-announces-preferred-stock-dividend/2026-04-10T12:00:00-04:00https://ir.neuraxis.com/neuraxis-reports-strong-fourth-quarter-and-full-year-2025-financial-results/2026-03-19T12:05:00-04:00